Schedule

SUNDAY, JUNE 11

MONDAY, JUNE 12

TUESDAY, JUNE 13

Register

Venue and Accommodations

The Adherence 2023 conference venue will be El Conquistador, which is located at 1000 Avenida El Conquistador, Fajardo, 00738, Puerto Rico.

The discounted hotel room rate is $226 per night plus tax and resort fee for June 10-14, 2023. Reservations must be made before 6:00 pm ET, Thursday, May 11, 2023. Click here to make your reservation today. If you wish to expand your stay outside of the available dates, please contact reservations@elconresort.com and reference Adherence 2023.

Submit an Abstract

Adherence 2023 will feature oral abstract and e-poster sessions. Below is guidance ahead of submitting your abstract(s) for the conference.

KEY DATES

Following are key dates relevant to abstract submissions:

• Abstract Submission Deadline – February 24, 2023
• Late-Breaker Abstract Submissions – March 27-31, 2023
• Abstract Disposition Announcements – March 31, 2023
• Late-Breaker Abstract Disposition Announcements – April 14, 2023
• Deadline to Withdraw Abstract/Change Presenting Author – May 5, 2023

CALL FOR ABSTRACTS

Abstract submissions are encouraged in a wide variety of specific domains, including:

• Antiretroviral therapy medication and medication adherence
• Linkage, retention, and re-engagement in HIV care
• Adherence and engagement in biomedical HIV prevention strategies
• Implementation science strategies
• Community engagement in planning, implementing, and monitoring HIV responses

Within these areas we encourage coverage of:

• Advances in basic science
• Innovative monitoring strategies
• Longitudinal or observational data
• Innovations in modeling and biopsychosocial theory
• Intervention development, implementation, and/or outcomes
• Dissemination/implementation of evidence-based approaches
• Operations research, demonstration projects, and practice-based approaches
• Health care policy and financing at local, state, and national levels
• Resource, structural, and service delivery issues and innovations
• Implementation science design, evidence, and real-world applicability
• Mitigation of HIV service disruption within the context of public health crises

Particularly as applied to key and disproportionately affected populations and settings:

• Treatment naïve, treatment experienced
• Individuals living with mental and/or physical health challenges
• Concomitant diseases (e.g., HBV, HCV, TB)
• Comorbid conditions (e.g., diabetes, hypertension)
• Syndemic conditions (e.g., mental health, substance use)
• Resource-constrained settings and geographies
• Key and vulnerable populations:
  • Men who have sex with men (MSM)
  • Transgender individuals
  • Women in high HIV incidence areas
  • Female and male sex workers
  • Pregnant women
  • Children and adolescents
  • Substance users
  • Incarcerated or recently released individuals
  • Homeless and/or marginally housed individuals

ABSTRACT SUBMISSION

Abstracts must be submitted online by 5 pm ET, February 24, 2023. Submitted abstracts will be considered for oral or e-poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to May 5, 2023.

It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.

ABSTRACT FORMAT

Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:

Format A: Data-Driven Abstracts

1. Background: a concise statement of the issues evaluated
2. Methods: the investigational model used
3. Results: specific findings
4. Conclusions: summary of findings, supported by results

Format B: Program Descriptions and Case Studies

1. Introduction: a concise statement of the issues addressed
2. Description: a description of the project, case study, experience, or intervention
3. Lessons Learned: project results, implementation issues, and/or case study solutions
4. Recommendations: further recommendations or next steps

GENERAL GUIDELINES

Following are some general guidelines for individuals interested in submitting an abstract(s):

• The abstract must NOT contain more than 300 words.
• Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
• Literature references and acknowledgements should not form any part of the abstract’s content.
• Figures and tables are acceptable, subject to high definition/quality guidance to be provided.
• The author is responsible for grammatical and factual details, and may edit an abstract after it has been submitted up to May 5, 2023.
• All abstracts must be submitted in English (without exception).
• Sub-specialty jargon should be avoided, reflecting the interdisciplinary nature of the conference.
• Define all abbreviations and concepts in your abstract at first use.
• For therapeutic agents, only generic names may be used (trade names are not permitted).

ABSTRACT SUBMISSION AND ACCEPTANCE

All abstracts must be submitted online no later than 5:00 pm ET, February 24, 2023. Submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.

Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book, during the Oral Abstract sessions, and during the e-Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than March 31, 2023. A notice of acceptance or rejection for late-breaker submissions will be sent via e-mail no later than April 14, 2023. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).

Accepted abstracts will be in one of two categories:

1.      Oral Abstract presentation
2.      e-Poster Abstract presentation

Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the e-Poster Session. Oral abstract and e-poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.

Note that only the abstracts of paid conference registrants will be included in the final Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish abstracts (including in the Journal of the International Association of Providers of AIDS Care [JIAPAC]) and online posting, if accepted. E-posters files must be transferred to IAPAC by June 2, 2023.

To reiterate, all abstract submissions must be received online by 5:00 pm ET, February 24, 2023. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5:00 pm ET, May 5, 2023. Abstracts may be withdrawn or the presenter may be changed until May 5, 2023.

Call for Nominations

IAPAC “Rising Star” Award for an Early Career HIV Adherence Researcher

IAPAC would like to recognize an early career researcher (i.e., within 5 years of their terminal degree) who has begun to develop expertise in any aspect of HIV adherence research. The recipient will be chosen based on their potential to move the field forward in new and exciting directions.

IAPAC Outstanding Contribution to HIV Adherence Award for a Senior Researcher

IAPAC would like to recognize a senior researcher (i.e., more than 10 years after their terminal degree) who has defined or significantly advanced one or more areas of the adherence field. The recipient will be chosen based on their scientific impact, as well as mentorship of junior investigators.

Please nominate yourself or another by submitting the following information here by May 12, 2023:

• Biosketch (NIH format)
• One letter (max 1 page) describing the nominee’s impact on the field of HIV adherence research; more than one person may contribute to the letter

Recipients will be strongly encouraged to attend the conference in person.

Contact

Abstract and Registration-related queries:

Cassandra Moore, cmoore@iapac.org

Exhibitor, Satellite, and Sponsorship-related queries:

Jonathon Hess, jhess@iapac.org

Hotel-related queries:

John Charles, jcharles@ftcinstitute.org

Conference Archives

• Adherence 2022
• Adherence 2021
• Adherence 2020
• Adherence 2019
• Adherence 2018
• Adherence 2017
• Adherence 2016
• Adherence 2015
• Adherence 2014
• Adherence 2013
• Adherence 2012
• Adherence 2011
• Adherence 2010
• Adherence